Developmental and epileptic encephalopathy, 11
MONDO:0013388Any early infantile epileptic encephalopathy in which the cause of the disease is a mutation in the SCN2A gene.
Also known as: DEE11, EIEE11, SCN2A early infantile epileptic encephalopathy, developmental and epileptic encephalopathy 11, early infantile epileptic encephalopathy caused by mutation in SCN2A, epileptic encephalopathy, early infantile, 11, epileptic encephalopathy, early infantile, type 11
21 clinical trials for this condition and its sub-types, 4 tagged with Developmental and epileptic encephalopathy, 11 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New hope for babies with rare seizure disorder: drug trial targets SCN2A gene
Disease control Recruiting nowThis study tests a medicine called elsunersen in 40 children with a rare, severe form of epilepsy caused by changes in the SCN2A gene. The goal is to see if the drug can safely reduce how often seizures happen over 24 weeks. Children must have started having seizures before 3 mon…
Phase 3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can mapping rare genetic variants unlock better care for autism-related disorders?
Knowledge-focused Recruiting nowThis international online study collects medical, behavioral, and developmental information from people with rare genetic changes that are linked to autism and other neurodevelopmental disorders. By partnering with families, researchers aim to build a detailed database to improve…
Sponsor: Simons Searchlight • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC